ADVB
Advanced Biomed Inc. Common Stock
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$9.34
−0.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.67x
- Price / sales
- —
- Price / cash flow
- -22.30x
Enterprise value
- Enterprise value
- $13.5M
- EV / sales
- —
- EV / EBITDA
- -13.47x
- EV / EBIT
- -12.35x
- Market cap
- $15.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026